Helen Torley - Feb 15, 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 15, 2024
Transactions value $
-$885,361
Form type
4
Date filed
2/16/2024, 05:39 PM
Previous filing
Feb 13, 2024
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +13.1K +2.05% $0.00 651K Feb 15, 2024 Direct
transaction HALO Common Stock Tax liability -$253K -7.04K -1.08% $35.91 644K Feb 15, 2024 Direct F1
transaction HALO Common Stock Award $0 +32.8K +5.09% $0.00 677K Feb 15, 2024 Direct F2
transaction HALO Common Stock Tax liability -$633K -17.6K -2.6% $35.91 659K Feb 15, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -13.1K -50% $0.00 13.1K Feb 15, 2024 Common Stock 13.1K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 7,036 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F2 This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.
F3 The reported disposition of 17,619 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F4 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.